Alogliptin Benzoate Patent Expiration
Alogliptin Benzoate is used for treating diabetes and associated disorders such as lipid and glucose metabolism issues. It was first introduced by Takeda Pharmaceuticals Usa Inc
Alogliptin Benzoate Patents
Given below is the list of patents protecting Alogliptin Benzoate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nesina | US6150383 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Nesina | US6211205 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Nesina | US6303640 | Pharmaceutical composition |
Aug 09, 2016
(Expired) | Takeda Pharms Usa |
| Nesina | US6303661 | Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals |
Apr 24, 2017
(Expired) | Takeda Pharms Usa |
| Nesina | US6329404 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Nesina | US6890898 | Method of regulating glucose metabolism, and reagents related thereto |
Feb 02, 2019
(Expired) | Takeda Pharms Usa |
| Nesina | US7078381 | Method of regulating glucose metabolism, and reagents related thereto |
Feb 02, 2019
(Expired) | Takeda Pharms Usa |
| Nesina | US7459428 | Method of regulating glucose metabolism, and reagents related thereto |
Feb 02, 2019
(Expired) | Takeda Pharms Usa |
| Nesina | US7807689 | Dipeptidyl peptidase inhibitors | Jun 27, 2028 | Takeda Pharms Usa |
| Nesina | US8173663 | Dipeptidyl peptidase inhibitors | Dec 02, 2025 | Takeda Pharms Usa |
| Nesina | US8288539 | Dipeptidyl peptidase inhibitors | Mar 15, 2025 | Takeda Pharms Usa |
| Nesina | US8697125 | Tablet preparation without causing a tableting trouble | Jun 16, 2029 | Takeda Pharms Usa |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳